Ver mas grande
LARS1 antibody
FT-FNab04701
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC, IF, IP |
| Target | LARS1 |
| Research Area | Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | leucyl-tRNA synthetase |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Leucine--tRNA ligase, cytoplasmic|Leucyl-tRNA synthetase (LeuRS, cLRS)|LARS1|KIAA1352|LARS |
| Host | Rabbit |
| UniProt ID | Q9P2J5 |
| Gene ID | 51520 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 135-140 kDa |
| Background | Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid(AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to h |
Más información
LARS antibody